TP53 and cancer: It must be noted that, in contrast with the wild type protein, mutant p53 isoforms fail to exert antioxidant activities and rather increase intracellular ROS, favoring cancer progression in parallel with different anabolic programs, as part of their Gain-of-function (GOF) phenotype (see below Section 1.3) [17].